The Keller Postman NEC lawsuit update for 2026 brings major developments for families seeking justice. Thousands of claims against baby formula manufacturers are moving through federal court, and the first bellwether trials are setting the tone for potential settlement talks.
If your premature infant developed necrotizing enterocolitis after being fed cow’s milk-based formula, this case could directly affect your family. The NEC MDL now includes over 1,000 pending cases in the Northern District of Illinois.
Here is what you need to know right now. This article covers settlement projections, eligibility rules, compensation tiers, filing deadlines, and every key milestone expected in 2026.
One fact that stands out: early trial verdicts have signaled that juries are willing to hold manufacturers accountable, which strengthens the position of every family with a pending claim.
Keller Postman NEC Lawsuit Update for 2026
The Keller Postman NEC lawsuit is actively progressing through the federal MDL system in 2026, with bellwether cases being prepared and settlement discussions gaining momentum. Keller Postman, now operating under the name Keller Lenkner, remains one of the leading firms representing families in this litigation.
As of early 2026, the MDL centralized in the Northern District of Illinois under Judge Rebecca Pallmeyer continues to grow. New cases are still being filed, and the court has established a structured discovery process that both sides are working through.
The biggest news this year centers on bellwether trial preparation. These test cases will be the first to go before a jury, and their outcomes will heavily influence whether Abbott Laboratories and Mead Johnson move toward a global settlement.
Keller Lenkner has been actively involved in case selection for these bellwether trials. Their legal team has worked on identifying cases with strong medical evidence linking formula use to NEC in premature infants.
| Detail | Info |
|---|---|
| MDL Case Number | MDL No. 3026 |
| Court | Northern District of Illinois |
| Presiding Judge | Judge Rebecca Pallmeyer |
| Lead Firm | Keller Lenkner (formerly Keller Postman) |
| Cases Filed | Over 1,000 as of early 2026 |
For families waiting on answers, the pace is picking up. The court has set firm deadlines, and both plaintiffs and defendants are preparing for trial.
NEC Lawsuit Settlement Amounts in 2026
NEC lawsuit settlement amounts in 2026 are projected to range from $50,000 to over $5 million per case, depending on injury severity and the strength of individual claims. No global settlement has been reached yet, but early trial results are shaping expectations.
The wide range reflects the difference between cases. A child who developed Stage I NEC and recovered fully will see a much lower settlement value than a family that lost a child or dealt with years of surgical intervention.

Legal analysts tracking the MDL have pointed to comparable mass tort cases for reference. The Zantac and talcum powder litigations offer loose benchmarks, but NEC cases involve infant injuries, which historically generate higher jury sympathy and larger verdicts.
- Wrongful death cases: $1 million to $5 million or more
- Surgical NEC with lasting complications: $500,000 to $2 million
- Stage II or III NEC with hospitalization: $250,000 to $750,000
- Stage I NEC with full recovery: $50,000 to $250,000
These numbers are estimates based on the severity framework courts typically use in product liability cases. Actual payouts will depend on bellwether outcomes and any negotiated settlement grid.
Keep in mind that no checks have been mailed yet. Settlement amounts will only become concrete once defendants agree to a deal or juries return verdicts that force the issue.
Who Qualifies for the NEC Formula Lawsuit
You may qualify for the NEC formula lawsuit if your premature infant was fed cow’s milk-based formula and later diagnosed with necrotizing enterocolitis. The connection between the formula and the NEC diagnosis is the core of every claim.
Eligibility comes down to a few key factors. The child must have been born premature, typically before 37 weeks of gestation. They must have received a cow’s milk-based formula product, specifically brands like Similac or Enfamil, during their NICU stay.
The NEC diagnosis must be documented in medical records. Courts require evidence that the infant actually developed NEC, not just general digestive issues. Stage I, II, and III NEC all qualify, along with surgical NEC.
| Requirement | Details |
|---|---|
| Birth Status | Premature (before 37 weeks) |
| Formula Type | Cow’s milk-based (Similac, Enfamil) |
| Diagnosis | Confirmed NEC (any stage) |
| Medical Records | Must document NEC diagnosis and formula use |
| Timeframe | NEC developed during or shortly after NICU stay |
Parents, guardians, and surviving family members can all file claims. If the infant passed away from NEC complications, wrongful death claims are being accepted.
There is no requirement that the family must have used the formula exclusively. Even partial formula feeding alongside breast milk may qualify.
Key Takeaway: The NEC MDL is growing fast in 2026, projected settlements range widely from $50,000 to over $5 million, and eligibility hinges on a premature infant being fed cow’s milk-based formula and developing a documented NEC diagnosis.
NEC Formula Lawsuit Payout Per Person
The NEC formula lawsuit payout per person will vary significantly based on the individual circumstances of each case. There is no flat payout amount because every child’s injury, treatment, and outcome are different.
Think of it like car insurance claims. A fender bender gets a small check. A totaled car with injuries gets a much larger one. NEC cases work the same way, with severity driving the number.
For families whose children survived with minimal lasting effects, payouts will land on the lower end of the spectrum. Cases involving multiple surgeries, long-term feeding complications, short bowel syndrome, or death will command the highest values.
Here is what shapes individual payout amounts:
- Severity of NEC (Stage I, II, or III)
- Whether surgery was required
- Duration of hospitalization beyond normal NICU stay
- Long-term health consequences for the child
- Whether the child survived
- Strength of medical evidence linking formula to NEC
Attorneys typically work on contingency in these cases. That means the law firm takes a percentage of the final payout, usually between 33% and 40%, and the family pays nothing upfront.
No individual settlement checks will go out until either a global settlement is reached or individual cases are resolved through trial verdicts. The timeline for actual payments is discussed in a later section.
NEC Lawsuit Bellwether Trial in 2026
The NEC lawsuit bellwether trials in 2026 represent the most important milestone in this litigation so far. Bellwether cases are test trials selected to gauge how juries respond to the evidence, and their outcomes will directly shape settlement negotiations.
In 2024, the first NEC bellwether trial resulted in a significant plaintiff verdict against Mead Johnson. That result sent a strong signal to both defendants. Juries are willing to find formula manufacturers liable for NEC injuries in premature infants.
For 2026, additional bellwether trials are scheduled or being prepared. The court has been working through the case selection process, choosing claims that represent different injury levels, different formula brands, and different fact patterns.
| Trial Element | Details |
|---|---|
| Purpose | Test jury response before global settlement |
| First Verdict | Plaintiff victory against Mead Johnson (2024) |
| 2026 Trials | Additional cases scheduled |
| Impact | Verdicts influence settlement value for all cases |
| Key Evidence | Medical records, expert testimony, internal company documents |
If plaintiffs continue winning at trial, Abbott and Mead Johnson will face enormous pressure to settle the entire MDL. Each defense loss increases the projected cost of fighting every case individually.
On the flip side, a defense win in a bellwether case could lower settlement expectations. That is why both sides treat these trials as make-or-break moments.
How to File an NEC Lawsuit Claim
Filing an NEC lawsuit claim starts with contacting a law firm that handles NEC baby formula cases. You do not file directly with the court yourself. An attorney handles the legal paperwork, court filings, and all communication with the defendants.
The process is simpler than most people expect. Here is what it looks like step by step:
- Contact a law firm handling NEC cases (like Keller Lenkner or another qualified firm)
- Provide basic information about your child’s birth, formula use, and NEC diagnosis
- Sign a retainer agreement (contingency fee, so no upfront cost)
- Gather medical records showing premature birth, formula feeding, and NEC diagnosis
- Your attorney files the case in the MDL or in state court
- Wait for discovery, trial, or settlement to proceed
Medical records are the single most important piece of your claim. Hospital NICU records, discharge summaries, and any surgical reports will form the backbone of your case.
You do not need to remember every detail. Your attorney’s team will request records directly from the hospital. Your job is to provide the names of the medical facilities and approximate dates.
Most families complete the initial intake process in a single phone call or online form. The heavy lifting falls on the legal team.
Key Takeaway: Bellwether trials are the engine driving this litigation forward, filing a claim requires an attorney and medical records, and the process costs families nothing upfront because firms work on contingency.
NEC Lawsuit Timeline for 2026
The NEC lawsuit timeline for 2026 is expected to include continued bellwether trials, expanded discovery, and the first serious settlement discussions if trial outcomes favor plaintiffs. This is a pivotal year for the litigation.
Here is how the year is shaping up:
| Period | Expected Activity |
|---|---|
| Q1 2026 | Continued case filings; discovery deadlines |
| Q2 2026 | Bellwether trial preparation; expert depositions |
| Q3 2026 | Potential bellwether trial dates; Daubert hearings |
| Q4 2026 | Settlement talks if trial results favor plaintiffs |
The MDL process is designed to move systematically, not quickly. Discovery alone involves millions of internal documents from Abbott and Mead Johnson. Both companies fought hard to limit what gets released, but the court has largely sided with plaintiffs on document production.
Expert witness battles will also heat up in 2026. Defendants are expected to challenge plaintiffs’ medical experts through Daubert motions, which ask the judge to exclude testimony the defense considers unreliable. These rulings could significantly impact trial outcomes.
For families, the practical takeaway is this: 2026 is a year of action, not waiting. The legal machinery is moving, and every milestone brings the case closer to resolution.
If you have not filed yet, doing so in early 2026 gives your claim the best chance of being included in any future settlement framework.
NEC Lawsuit Compensation Tiers Explained
NEC lawsuit compensation tiers refer to the system courts and settlement administrators use to categorize claims by injury severity and assign corresponding payout ranges. This is how mass tort cases handle thousands of individual claims without separate trials for each one.
In most mass tort settlements, a tiered structure groups cases into categories. Higher tiers receive more money because the injuries are more severe.
Here is a projected tier structure based on how similar mass tort cases have been organized:
| Tier | Injury Description | Estimated Range |
|---|---|---|
| Tier 1 | Stage I NEC, full recovery, short hospitalization | $50,000 to $150,000 |
| Tier 2 | Stage II NEC, extended hospitalization, no surgery | $150,000 to $400,000 |
| Tier 3 | Stage II/III NEC requiring surgery | $400,000 to $1,000,000 |
| Tier 4 | Surgical NEC with permanent complications (short bowel syndrome) | $1,000,000 to $2,500,000 |
| Tier 5 | Wrongful death | $2,000,000 to $5,000,000+ |
These tiers are not finalized. They represent informed projections based on bellwether trial results and comparable mass tort settlements.
What pushes a case into a higher tier is straightforward. More severe NEC staging, surgical intervention, lasting health damage, and death all increase value. Strong medical records documenting the link between formula and NEC also matter.
Your attorney will evaluate where your case falls within this framework and fight for the highest tier your evidence supports.
NEC MDL Status Update for 2026
The NEC MDL status in 2026 shows a mature, active litigation with over 1,000 cases consolidated before Judge Rebecca Pallmeyer in the Northern District of Illinois. The MDL number is 3026, and it covers all federal claims related to NEC injuries from cow’s milk-based infant formula.
The Judicial Panel on Multidistrict Litigation transferred these cases to a single court for coordinated pretrial proceedings. This means discovery, expert challenges, and bellwether trials all happen in one place, even though individual families filed from across the country.
As of 2026, the MDL is past its early organizational phase. Key developments include:
- Plaintiffs’ Steering Committee has been appointed and is actively managing case strategy
- Document discovery from Abbott and Mead Johnson is ongoing
- Bellwether case selection is complete or nearing completion
- Expert reports have been exchanged between both sides
- Daubert challenges to expert testimony are being briefed
The MDL structure benefits families because it pools resources. Instead of each family paying for their own experts and discovery, the lead attorneys handle it collectively. Individual families still retain their own lawyers, but the MDL leadership drives the overall strategy.
New cases continue to be filed and added to the MDL. The court has not set a cutoff for new filings, though filing sooner remains advisable.
Key Takeaway: The NEC MDL in 2026 is a mature litigation with over 1,000 cases, compensation tiers will likely range from $50,000 to $5 million based on severity, and the court has moved past organizational stages into active trial preparation.
Keller Postman’s Role in the NEC MDL
Keller Postman, now known as Keller Lenkner, plays a significant leadership role in the NEC MDL. The firm was among the earliest to file NEC baby formula claims and has been instrumental in shaping the litigation strategy against Abbott and Mead Johnson.
In mass tort cases, the court appoints a Plaintiffs’ Steering Committee to coordinate the work of all plaintiff attorneys. Keller Lenkner has been involved in this leadership structure, contributing to decisions about bellwether case selection, expert witness strategy, and discovery priorities.
What does that mean for your case? If Keller Lenkner represents you, your claim benefits from the firm’s direct involvement in the MDL’s decision-making process. They have access to internal company documents obtained through discovery, and they participate in strategy meetings with the court.
The firm handles NEC cases on a contingency basis. You pay nothing unless your case results in a settlement or verdict.
- Firm Name Change: Keller Postman rebranded to Keller Lenkner
- MDL Role: Leadership participation in plaintiffs’ strategy
- Case Volume: Represents a significant number of NEC claimants
- Fee Structure: Contingency (percentage of recovery, no upfront cost)
Even if you are not represented by Keller Lenkner, their work on the MDL benefits all plaintiffs. The bellwether cases they help prepare set the value benchmark for everyone.
Similac and Enfamil NEC Lawsuit Details
The Similac and Enfamil NEC lawsuit targets the two most widely used cow’s milk-based formula brands given to premature infants in hospital NICUs. Abbott Laboratories makes Similac. Mead Johnson, now owned by Reckitt Benckiser, makes Enfamil.

Plaintiffs allege that both companies knew or should have known that their cow’s milk-based formulas posed a heightened risk of NEC in premature infants. Despite scientific literature dating back decades, neither company added adequate warnings to their products.
The core legal theory is failure to warn. Hospitals and parents trusted these brands because they were presented as safe for premature babies. Plaintiffs argue that marketing materials actually encouraged NICU use of these formulas without disclosing the NEC risk.
| Brand | Manufacturer | Parent Company | Key Products at Issue |
|---|---|---|---|
| Similac | Abbott Laboratories | Abbott | Similac Special Care, Similac Human Milk Fortifier |
| Enfamil | Mead Johnson | Reckitt Benckiser | Enfamil Premature, Enfamil Human Milk Fortifier |
Internal company documents obtained during discovery have become a focal point. Plaintiffs claim these documents show that the manufacturers had access to studies linking cow’s milk formula to NEC but chose not to act on them.
Both defendants deny wrongdoing. They maintain their products are safe and that NEC has multiple causes unrelated to formula feeding.
NEC Lawsuit Eligibility Requirements
NEC lawsuit eligibility requirements center on three core elements: premature birth, cow’s milk-based formula use, and a confirmed NEC diagnosis. If your child meets all three, you likely have a viable claim.
Let’s break each requirement down clearly.
Premature birth means the child was born before 37 weeks of gestation. Most NEC cases in this litigation involve very premature infants born before 32 weeks, but claims for infants born between 32 and 37 weeks are also being accepted.
Formula use means the child was fed a cow’s milk-based product during their NICU stay. This includes Similac, Enfamil, and their specialized premature infant versions. Even if breast milk was also given, partial formula feeding can still qualify.
NEC diagnosis must appear in the child’s medical records. A clinical diagnosis of necrotizing enterocolitis at any stage (I, II, or III) meets this requirement. Surgical NEC and NEC-related death also qualify.
Additional factors that strengthen a claim:
- Surgery to remove dead bowel tissue
- Short bowel syndrome as a lasting complication
- Extended NICU stay due to NEC treatment
- Multiple surgeries or procedures related to NEC
- Death caused by NEC or its complications
There is no minimum age requirement for when the NEC occurred, and claims can be filed by parents, legal guardians, or estate representatives in wrongful death cases.
Key Takeaway: Eligibility requires three things (premature birth, formula use, NEC diagnosis), Similac and Enfamil are the primary brands at issue, and even partial formula feeding alongside breast milk can qualify your family for a claim.
When Will NEC Lawsuit Settlements Be Paid
NEC lawsuit settlements are not expected to be paid until late 2026 at the earliest, with a more realistic timeline pointing to 2027 or later. No global settlement has been reached yet, so no payment schedule exists.
Here is the honest truth about mass tort timelines. Even after a settlement deal is announced, it takes months for the claims administration process to begin. Every individual claim has to be reviewed, verified, and assigned a payment tier. That process alone can take six months to a year.
The sequence before payments go out looks like this:
- Bellwether trials produce verdicts
- Defendants agree to negotiate a global settlement
- A settlement amount is finalized
- A claims administrator is appointed
- Individual claims are submitted and reviewed
- Payment tiers are assigned
- Checks are distributed
For context, the 3M earplug MDL took about 18 months from settlement announcement to first payments. The Roundup litigation took even longer. NEC families should prepare for a similar timeline.
| Milestone | Projected Timing |
|---|---|
| Bellwether verdicts | 2025 through 2026 |
| Settlement negotiations begin | Late 2026 |
| Settlement announced | 2027 (projected) |
| Claims review process | 6 to 12 months after announcement |
| First payments distributed | Late 2027 to 2028 (projected) |
Filing your claim now ensures you are in line when payments begin. Waiting only delays your position.
NEC in Premature Infants From Formula
NEC in premature infants from formula refers to the medical condition necrotizing enterocolitis, a devastating intestinal disease that primarily strikes premature babies. Research has shown that cow’s milk-based formula significantly increases the risk compared to exclusive breast milk feeding.
NEC occurs when portions of the intestinal lining die and become inflamed. In severe cases, the bowel wall perforates, allowing bacteria to leak into the abdomen. This can lead to sepsis, organ failure, and death.
Premature infants are vulnerable because their intestinal tracts are not fully developed. The proteins in cow’s milk formula are harder for immature guts to process. This creates inflammation that can escalate rapidly.
The medical staging system works like this:
- Stage I (Suspected NEC): Mild symptoms like feeding intolerance and abdominal distension
- Stage II (Confirmed NEC): Intestinal wall thickening visible on imaging, bloody stools
- Stage III (Advanced NEC): Bowel perforation, peritonitis, potential organ failure
Studies published in medical journals like Pediatrics and The Lancet have documented the elevated NEC risk from cow’s milk formula for decades. Plaintiffs argue that formula manufacturers were aware of this research but failed to warn hospitals or parents.
Breast milk, especially donor human milk, has been shown to significantly reduce NEC incidence. This contrast is central to the plaintiffs’ argument.
Baby Formula Brands Named in the NEC Lawsuit
The baby formula brands named in the NEC lawsuit are primarily Similac and Enfamil, along with their specialized premature infant product lines. These are the two dominant brands used in American NICUs.
Here is a breakdown of the specific products at issue:
| Brand | Product Name | Target Use |
|---|---|---|
| Similac | Similac Special Care | Premature infants in NICU |
| Similac | Similac Human Milk Fortifier | Added to breast milk for premature infants |
| Similac | Similac NeoSure | Post-discharge premature infant formula |
| Enfamil | Enfamil Premature | Premature infants in NICU |
| Enfamil | Enfamil Human Milk Fortifier | Added to breast milk for premature infants |
| Enfamil | Enfamil NeuroPro EnfaCare | Post-discharge premature infant formula |
Human milk fortifiers are included because they contain cow’s milk proteins. Even when a mother provides breast milk, adding a cow’s milk-based fortifier may introduce the same NEC risk.
Abbott Laboratories manufactures all Similac products. Mead Johnson, now a subsidiary of Reckitt Benckiser, manufactures all Enfamil products. Both companies are defendants in the MDL.
Store-brand or generic formulas are not currently named in this litigation. The focus is on the two manufacturers that dominate the NICU market.
If your child received any of these specific products during their hospital stay, your family may have a claim.
Key Takeaway: Settlements are projected for 2027 or later with a lengthy claims review process, NEC is a severe intestinal disease caused by cow’s milk proteins in premature guts, and the lawsuit targets specific Similac and Enfamil products including human milk fortifiers used in NICUs.
NEC Lawsuit Statute of Limitations in 2026
The NEC lawsuit statute of limitations in 2026 varies by state, but most families still have time to file. Statutes of limitations for personal injury and wrongful death claims involving minors often include special extensions that give families more time than standard deadlines.
Every state sets its own rules. Some states give families two years from the date of injury. Others allow three or four years. When the injured person is a minor, many states pause the clock until the child turns 18, then give an additional period.
Here is a general look at common state deadlines:
| State | Standard Personal Injury Limit | Minor Exception |
|---|---|---|
| California | 2 years | Tolled until age 18 |
| Texas | 2 years | Tolled until age 18 |
| New York | 3 years | Tolled until age 18 |
| Florida | 4 years (recently changed to 2) | Tolled until age 18 |
| Illinois | 2 years | Tolled until age 18 |
The “tolling” for minors means the clock does not start running until the child reaches adulthood. For an infant who developed NEC in 2022, the statute may not expire until they turn 18, plus the additional state-specific period.
However, waiting is risky. Medical records can be harder to obtain over time. Witnesses’ memories fade. Evidence gets lost.
Filing sooner gives your attorney more time to build a strong case. Even if the statute has not expired, starting early is always the smarter strategy.
There is one more factor. The “discovery rule” applies in some states. This means the clock starts when the family reasonably should have known that formula caused the NEC, not necessarily when the injury occurred. This rule has helped some families file claims years after the initial diagnosis.
Your attorney can evaluate your specific state’s rules and determine whether your claim falls within the deadline. Do not assume you are too late without checking.
Frequently Asked Questions
How much money can I get from the NEC baby formula lawsuit?
Most estimates range from $50,000 to over $5 million depending on injury severity.
Wrongful death and surgical NEC cases with lasting complications receive the highest values.
No payments have been made yet because a global settlement has not been finalized.
Is it too late to file an NEC lawsuit in 2026?
Most families can still file in 2026 because statutes of limitations for minors are extended in nearly every state.
The MDL is still accepting new cases, and no filing cutoff has been announced by the court.
Filing sooner gives your attorney more time to build a strong claim.
What does Keller Postman do in the NEC lawsuit?
Keller Postman, now called Keller Lenkner, serves in a leadership role within the NEC MDL’s plaintiffs’ structure.
They help select bellwether cases, manage discovery, and shape the overall litigation strategy.
The firm represents individual families on a contingency basis with no upfront fees.
Which baby formula brands are being sued for causing NEC?
Similac (made by Abbott Laboratories) and Enfamil (made by Mead Johnson/Reckitt Benckiser) are the primary brands named.
Specific products include Similac Special Care, Enfamil Premature, and both brands’ human milk fortifiers.
Generic or store-brand formulas are not currently part of this litigation.
When will NEC lawsuit settlement checks be mailed out?
Settlement checks are not expected before late 2027 at the earliest.
A global settlement must be reached first, followed by a claims review process that could take six months to a year.
Filing your claim now ensures you are in position when payments begin.
What to Do Right Now
The NEC baby formula litigation is at a turning point in 2026. Bellwether trials are shaping settlement expectations, and every new plaintiff verdict strengthens the case for all families.
If your premature infant developed NEC after receiving Similac or Enfamil, gather your child’s medical records and speak with an attorney handling NEC cases. The filing window is open, but waiting only works against you.
This is the year that could define the outcome for thousands of families. Get your claim on file and stay informed as the case moves forward.









